Financhill
Sell
37

EIX Quote, Financials, Valuation and Earnings

Last price:
$55.93
Seasonality move :
2.66%
Day range:
$54.51 - $55.45
52-week range:
$49.06 - $88.77
Dividend yield:
5.86%
P/E ratio:
7.78x
P/S ratio:
1.23x
P/B ratio:
1.41x
Volume:
2M
Avg. volume:
3.5M
1-year change:
-24.91%
Market cap:
$21.1B
Revenue:
$17.6B
EPS (TTM):
$7.05
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $13.6B $14.9B $17.2B $16.3B $17.6B
Revenue Growth (YoY) 9.97% 9.77% 15.53% -5.12% 7.72%
 
Cost of Revenues $8.5B $9.2B $11.1B $9.6B $10.4B
Gross Profit $5B $5.7B $6.1B $6.7B $7.2B
Gross Profit Margin 37.1% 38.38% 35.55% 41.09% 41.01%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.7B $1.5B $1.5B $880M $798M
Other Inc / (Exp) $482M $164M $209M $232M $243M
Operating Expenses $4.1B $4.2B $4.6B $4.1B $4.3B
Operating Income $968M $1.5B $1.5B $2.6B $2.9B
 
Net Interest Expenses $884M $921M $1.1B $1.3B $1.6B
EBT. Incl. Unusual Items $566M $789M $662M $1.5B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$305M -$136M -$162M $108M $17M
Net Income to Company $942M $925M $824M $1.4B $1.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $871M $925M $824M $1.4B $1.5B
 
Basic EPS (Cont. Ops) $1.98 $2.00 $1.61 $3.12 $3.33
Diluted EPS (Cont. Ops) $1.98 $2.00 $1.60 $3.11 $3.31
Weighted Average Basic Share $373M $380M $381M $383M $386M
Weighted Average Diluted Share $374M $380M $383M $385M $388M
 
EBITDA $3.5B $4B $4.5B $5.8B $6.4B
EBIT $1.5B $1.7B $1.8B $3.1B $3.4B
 
Revenue (Reported) $13.6B $14.9B $17.2B $16.3B $17.6B
Operating Income (Reported) $968M $1.5B $1.5B $2.6B $2.9B
Operating Income (Adjusted) $1.5B $1.7B $1.8B $3.1B $3.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3B $4B $4B $4.1B $3.8B
Revenue Growth (YoY) 6.09% 34.05% -0.05% 2.82% -6.55%
 
Cost of Revenues $1.9B $2.5B $2.4B $2.3B $2B
Gross Profit $1.1B $1.4B $1.6B $1.8B $1.8B
Gross Profit Margin 37.37% 36.39% 39.44% 42.99% 46.73%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $56M $478M $148M $651M -$1.3B
Other Inc / (Exp) $72M $66M $57M $71M $54M
Operating Expenses $707M $1.2B $944M $1.5B -$361M
Operating Income $399M $259M $620M $245M $2.1B
 
Net Interest Expenses $217M $244M $299M $377M $256M
EBT. Incl. Unusual Items $254M $81M $378M -$61M $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$36M -$55M $13M -$113M $448M
Net Income to Company $290M $136M $365M $52M $1.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $290M $136M $365M $52M $1.5B
 
Basic EPS (Cont. Ops) $0.68 $0.22 $0.81 -$0.03 $3.73
Diluted EPS (Cont. Ops) $0.68 $0.22 $0.81 -$0.03 $3.73
Weighted Average Basic Share $379M $381M $383M $385M $385M
Weighted Average Diluted Share $380M $382M $384M $385M $386M
 
EBITDA $1B $951M $1.4B $1.1B $3B
EBIT $471M $327M $739M $383M $2.2B
 
Revenue (Reported) $3B $4B $4B $4.1B $3.8B
Operating Income (Reported) $399M $259M $620M $245M $2.1B
Operating Income (Adjusted) $471M $327M $739M $383M $2.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $13.7B $15.9B $17.2B $16.5B $17.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.6B $9.9B $11B $9.5B $10.1B
Gross Profit $5.2B $6.1B $6.2B $6.9B $7.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.6B $1.9B $1.2B $1.4B -$1.1B
Other Inc / (Exp) $512M $158M $197M $246M $226M
Operating Expenses $4.1B $4.7B $4.3B $4.7B $2.4B
Operating Income $1.1B $1.4B $1.9B $2.3B $4.8B
 
Net Interest Expenses $886M $948M $1.1B $1.4B $1.5B
EBT. Incl. Unusual Items $691M $616M $959M $1.1B $3.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$257M -$155M -$94M -$18M $578M
Net Income to Company $1B $771M $1.1B $1.1B $3B
 
Minority Interest in Earnings -- -- -- -$29M -$49M
Net Income to Common Excl Extra Items $948M $771M $1.1B $1.1B $2.9B
 
Basic EPS (Cont. Ops) $2.16 $1.54 $2.20 $2.27 $7.08
Diluted EPS (Cont. Ops) $2.16 $1.53 $2.19 $2.27 $7.05
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.6B $3.9B $4.9B $5.5B $8.3B
EBIT $1.6B $1.6B $2.2B $2.8B $5.3B
 
Revenue (Reported) $13.7B $15.9B $17.2B $16.5B $17.3B
Operating Income (Reported) $1.1B $1.4B $1.9B $2.3B $4.8B
Operating Income (Adjusted) $1.6B $1.6B $2.2B $2.8B $5.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3B $4B $4B $4.1B $3.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.9B $2.5B $2.4B $2.3B $2B
Gross Profit $1.1B $1.4B $1.6B $1.8B $1.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $56M $478M $148M $651M -$1.3B
Other Inc / (Exp) $72M $66M $57M $71M $54M
Operating Expenses $707M $1.2B $944M $1.5B -$361M
Operating Income $399M $259M $620M $245M $2.1B
 
Net Interest Expenses $217M $244M $299M $377M $256M
EBT. Incl. Unusual Items $254M $81M $378M -$61M $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$36M -$55M $13M -$113M $448M
Net Income to Company $290M $136M $365M $52M $1.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $290M $136M $365M $52M $1.5B
 
Basic EPS (Cont. Ops) $0.68 $0.22 $0.81 -$0.03 $3.73
Diluted EPS (Cont. Ops) $0.68 $0.22 $0.81 -$0.03 $3.73
Weighted Average Basic Share $379M $381M $383M $385M $385M
Weighted Average Diluted Share $380M $382M $384M $385M $386M
 
EBITDA $1B $951M $1.4B $1.1B $3B
EBIT $471M $327M $739M $383M $2.2B
 
Revenue (Reported) $3B $4B $4B $4.1B $3.8B
Operating Income (Reported) $399M $259M $620M $245M $2.1B
Operating Income (Adjusted) $471M $327M $739M $383M $2.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $87M $390M $914M $345M $193M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1B $1.4B $1.7B $2B $2.2B
Inventory $405M $420M $474M $527M $538M
Prepaid Expenses $281M $258M $248M $112M $103M
Other Current Assets $1.9B $2.2B $3.1B $3.1B $3.3B
Total Current Assets $5.1B $5.5B $7.1B $6.8B $7.2B
 
Property Plant And Equipment $48.9B $52.6B $54.9B $57.3B $60.4B
Long-Term Investments $4.9B $4.9B $4B $4.2B $4.3B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $3.3B $3.8B $3.4B $4B $4.3B
Total Assets $69.4B $74.7B $78B $81.8B $85.6B
 
Accounts Payable $2B $2B $2.4B $2B $2B
Accrued Expenses -- -- -- $390M $422M
Current Portion Of Long-Term Debt $3.4B $3.4B $4.6B $3.8B $3B
Current Portion Of Capital Lease Obligations $215M $582M $506M $120M $124M
Other Current Liabilities $4.4B $2.4B $2.7B $2.3B $2.8B
Total Current Liabilities $10.3B $8.6B $10.3B $8.6B $8.4B
 
Long-Term Debt $19.6B $24.2B $27B $30.3B $33.5B
Capital Leases -- -- -- -- --
Total Liabilities $53.4B $57B $60.5B $63.8B $67.8B
 
Common Stock $6B $8B $8.2B $8B $8B
Other Common Equity Adj -$69M -$54M -$11M -$9M --
Common Equity $14B $13.9B $13.6B $13.8B $13.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9B $1.9B $1.9B $2.4B $2.2B
Total Equity $15.9B $17.8B $17.5B $17.9B $17.7B
 
Total Liabilities and Equity $69.4B $74.7B $78B $81.8B $85.6B
Cash and Short Terms $87M $390M $914M $345M $193M
Total Debt $23.1B $27.6B $31.7B $34.1B $36.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $389M $231M $836M $992M $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1B $1.3B $1.5B $1.9B $1.9B
Inventory $416M $434M $500M $519M $539M
Prepaid Expenses $163M $258M $311M $244M $262M
Other Current Assets $2B $2.3B $3.3B $3.5B $2.6B
Total Current Assets $5.3B $5.3B $7.2B $7.9B $7.4B
 
Property Plant And Equipment $49.4B $52.8B $55.5B $57.9B $61.3B
Long-Term Investments $4.8B $4.6B $4.2B $4.4B $4.3B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $3.4B $3.8B $3.4B $4.2B $4.3B
Total Assets $70.5B $74.7B $78.9B $83.6B $88.4B
 
Accounts Payable $1.6B $2B $1.8B $1.9B $2.2B
Accrued Expenses -- -- -- $440M $495M
Current Portion Of Long-Term Debt $3.4B $3.2B $3.9B $2.9B $3B
Current Portion Of Capital Lease Obligations $215M $594M $420M $119M $123M
Other Current Liabilities $4B $2.4B $2.1B $2.6B $2B
Total Current Liabilities $9.5B $8.3B $8.4B $7.9B $7.8B
 
Long-Term Debt $20.2B $25B $29.4B $32.6B $35.4B
Capital Leases -- -- -- -- --
Total Liabilities $53.3B $57.1B $61.3B $66B $69.6B
 
Common Stock $7.2B $8.1B $8.2B $8B $8B
Other Common Equity Adj -$67M -$52M -$9M -$9M --
Common Equity -- -- -- -- --
Total Preferred Equity $1.2B -- -- -$19M --
Minority Interest, Total $1.9B $1.9B $1.9B $2.4B $2.2B
Total Equity $17.2B $17.6B $17.5B $17.6B $18.8B
 
Total Liabilities and Equity $70.5B $74.7B $78.9B $83.6B $88.4B
Cash and Short Terms $389M $231M $836M $992M $1.3B
Total Debt $23.6B $28.1B $33.3B $35.4B $38.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $942M $925M $824M $1.4B $1.5B
Depreciation & Amoritzation $2B $2.3B $2.6B $2.7B $2.9B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $642M $194M -$642M -$385M -$195M
Change in Inventories -$43M -$21M -$58M -$63M -$14M
Cash From Operations $1.4B $11M $3.2B $3.4B $5B
 
Capital Expenditures $5.5B $5.5B $5.8B $5.4B $5.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$5.1B -$5.2B -$5.6B -$5.2B -$5.5B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1B -$1.1B -$1.2B -$1.3B
Special Dividend Paid
Long-Term Debt Issued $5B $8.1B $7B $7.3B $5.6B
Long-Term Debt Repaid -$1B -$3.5B -$2.9B -$4.9B -$3.1B
Repurchase of Common Stock -$308M -- -- -$289M -$856M
Other Financing Activities $1.4B -$61M $4M $20M $9M
Cash From Financing $3.7B $5.4B $2.9B $1.4B $674M
 
Beginning Cash (CF) $24M $89M $394M $917M $532M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $32M $305M $523M -$385M $152M
Ending Cash (CF) $56M $394M $917M $532M $684M
 
Levered Free Cash Flow -$4.1B -$5.5B -$2.6B -$2B -$693M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $290M $136M $365M $52M $1.5B
Depreciation & Amoritzation $542M $624M $676M $707M $742M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $120M $34M $227M $84M $281M
Change in Inventories -$12M -$14M -$29M $5M -$1M
Cash From Operations $72M $792M -$90M $1B $1.2B
 
Capital Expenditures $1.4B $1.2B $1.3B $1.3B $1.4B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.3B -$1.2B -$1.3B -$1.3B -$1.4B
 
Dividends Paid (Ex Special Dividend) -$247M -$308M -$329M -$339M -$363M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B $1.7B $2.6B $3B $3.5B
Long-Term Debt Repaid -$997M -$1.2B -$1B -$1.6B -$1.7B
Repurchase of Common Stock -- -- -- -$19M -$29M
Other Financing Activities -$25M -$15M -$5M -$17M -$47M
Cash From Financing $1.5B $205M $1.3B $988M $1.4B
 
Beginning Cash (CF) $89M $394M $917M $532M $684M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $301M -$160M -$79M $755M $1.2B
Ending Cash (CF) $390M $234M $838M $1.3B $1.9B
 
Levered Free Cash Flow -$1.3B -$415M -$1.4B -$236M -$184M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1B $771M $1.1B $1.1B $3B
Depreciation & Amoritzation $2.1B $2.4B $2.7B $2.8B $3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $734M $108M -$449M -$528M $2M
Change in Inventories -$56M -$23M -$73M -$29M -$20M
Cash From Operations $1.2B $731M $2.3B $4.5B $5.2B
 
Capital Expenditures $5.6B $5.4B $5.9B $5.4B $5.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$5.1B -$5B -$5.7B -$5.2B -$5.6B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.1B -$1.2B -$1.2B -$1.3B
Special Dividend Paid
Long-Term Debt Issued $3.6B $8.3B $7.9B $7.6B $6.1B
Long-Term Debt Repaid -$1.4B -$3.7B -$2.8B -$5.5B -$3.2B
Repurchase of Common Stock -- -- -- -$308M -$866M
Other Financing Activities $1.4B -$51M $14M $8M -$21M
Cash From Financing $3B $4.1B $4B $1.1B $1.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$935M -$156M $604M $449M $621M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$4.4B -$4.6B -$3.6B -$869M -$641M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $290M $136M $365M $52M $1.5B
Depreciation & Amoritzation $542M $624M $676M $707M $742M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $120M $34M $227M $84M $281M
Change in Inventories -$12M -$14M -$29M $5M -$1M
Cash From Operations $72M $792M -$90M $1B $1.2B
 
Capital Expenditures $1.4B $1.2B $1.3B $1.3B $1.4B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.3B -$1.2B -$1.3B -$1.3B -$1.4B
 
Dividends Paid (Ex Special Dividend) -$247M -$308M -$329M -$339M -$363M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B $1.7B $2.6B $3B $3.5B
Long-Term Debt Repaid -$997M -$1.2B -$1B -$1.6B -$1.7B
Repurchase of Common Stock -- -- -- -$19M -$29M
Other Financing Activities -$25M -$15M -$5M -$17M -$47M
Cash From Financing $1.5B $205M $1.3B $988M $1.4B
 
Beginning Cash (CF) $89M $394M $917M $532M $684M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $301M -$160M -$79M $755M $1.2B
Ending Cash (CF) $390M $234M $838M $1.3B $1.9B
 
Levered Free Cash Flow -$1.3B -$415M -$1.4B -$236M -$184M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 32.84% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 0.09% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 20.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock